astria therapeutics glp-1 receptor agonist weight management diabetes treatments agonists are transforming care by improving blood sugar control, supporting loss, and reducing cardiovascular risk when used appropriately. Evidence-based therapy selection, correct dosing, and patient counseling are GLP-1 Receptor Agonists as Treatments
Description
However, GLP-1 is quickly degraded in the body leading to a short time of action
Rodriguez R, Moreno M, Lee AY, Godoy-Lugo JA, Nakano D, Nishiyama A, et al
Plan sponsors need to adopt formulary and benefit designs that account for this and make sure that GLP-1s are used for the indication prescribed
Common adverse effects of GLP1RAs include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which are dose-dependent and may impair nutritional intake
